Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Other Non-Current Assets (2023 - 2025)

Metagenomi (MGX) has disclosed Other Non-Current Assets for 3 consecutive years, with $5.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $5.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.2 million, a 0.0% change, with the full-year FY2024 number at $5.2 million, down 4.44% from a year prior.
  • Other Non-Current Assets was $5.2 million for Q3 2025 at Metagenomi, roughly flat from $5.2 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $6.1 million in Q1 2023 to a low of $5.2 million in Q2 2023.
  • A 3-year average of $5.4 million and a median of $5.2 million in 2023 define the central range for Other Non-Current Assets.
  • Biggest YoY gain for Other Non-Current Assets was 0.0% in 2024; the steepest drop was 13.58% in 2024.
  • Metagenomi's Other Non-Current Assets stood at $5.5 million in 2023, then dropped by 4.44% to $5.2 million in 2024, then changed by 0.0% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Other Non-Current Assets are $5.2 million (Q3 2025), $5.2 million (Q2 2025), and $5.2 million (Q1 2025).